St James's University Hospital
St James's University Hospital is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
MRD registry and multicenter, randomized controlled pragmatic trial of standard intensity versus reduced intensity consolidation treatment in MRD-negative patients with AML or CLL (RESOLVE trial).
Sponsor Medizinische Hochschule Hannover
- Start (EU)
- Latest update
- Estimated end
- Not reported
BEACON2: A multi-arm multi-stage platform trial for relapsed neuroblastoma
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Sponsor BeOne Medicines AG
- Start (EU)
- Latest update
- Estimated end
BEACON: A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for St James's University Hospital?
The 2026-10-09 snapshot links St James's University Hospital to 5 distinct CTIS trials. Recorded services include Laboratory services, Biobank. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for St James's University Hospital?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to St James's University Hospital conducted?
The linked trials record locations in 13 countries, including France, Spain, Italy, Austria, Belgium. These are trial locations, not confirmed office locations or countries where St James's University Hospital delivered services.
What can this page tell me about St James's University Hospital's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under St James's University Hospital. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- St James's University Hospital